Condition
Drug Withdrawal
Total Trials
4
Recruiting
1
Active
1
Completed
3
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
1Total
P 4 (1)
Trial Status
Completed3
Recruiting1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT05461820Phase 4Recruiting
Effects of Different Treatment Schemes on the Regulation and Recurrence of Graves' Disease
NCT06029634Completed
Effects of T-bet B Cells in Persistent Virus Control After Discontinuance of NAs in CHB Patients
NCT04320381Completed
Qualitative Understanding of Experiences With the SIMPLIFY Trial
NCT03909191Completed
Serum HBV RNA Value on Chronic Hepatitis B Virus Infection Manage
Showing all 4 trials